CytoDyn Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-50.1M | $-25.8M | $-25.7M | $-25.1M | $-12.4M | $-9.6M | $-7.5M | $-3.7M |
| Depreciation & Amortization | $356.1K | $366.4K | $361.6K | $360.6K | $352.4K | $222.7K | $2.0K | $2.9K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | $350.0K | $219.0K | — | — |
| Stock-Based Compensation | $1.3M | $1.2M | $2.4M | $631.3K | $928.4K | $3.6M | $2.9M | $1.2M |
| Net Cash from Operating Activities | $-29.9M | $-26.7M | $-24.8M | $-12.0M | $-7.4M | $-3.4M | $-4.4M | $-1.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $11.1K | $11.9K | $18.6K | $19.2K | $3.1K | — | $4.7K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $-11.1K | $-11.9K | — | $-19.2K | $-3.5M | — | $-4.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $29.4M | $18.9M | $33.4M | — | — | $7.2M | $3.6M | $2.2M |
| Net Change in Cash | $-544.1K | $-7.9M | $8.6M | $-3.8M | $4.3M | $318.7K | $-752.8K | $337.3K |
| Free Cash Flow | $-29.9M | $-26.7M | $-24.8M | $-12.0M | $-7.4M | $-3.4M | — | $-1.8M |